Drugs / Vero cell derived, trivalent, seasonal influenza vaccine
Vero cell derived, trivalent, seasonal influenza vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00800605 | Dec 2008 → May 2009 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00782431 | Nov → Dec 2008 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vero cell derived, trivalent, seasonal influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00782431 ↗ |
| Modality | Vaccine | “Vero cell-derived, trivalent, seasonal influenza vaccine” NCT00782431 ↗ |
| Route | Intramuscular | “Single intramuscular injection” NCT00782431 ↗ |